Lipid Profile Alterations in the Metabolic Syndrome The Latest Biochemical and Physiological Aspect

§ SKIMS

Send Message

To: Author

Lipid Profile Alterations in the Metabolic Syndrome The Latest Biochemical and Physiological Aspect

Article Fingerprint

ReserarchID

MRQQO7N

Lipid Profile Alterations in the Metabolic Syndrome The Latest Biochemical and Physiological Aspect Banner

Key Research Insights

Synthesized scholarly intelligence & interactive research assistant
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
Reading Preferences
Font Size
Line Spacing
Background

Abstract

Cardiovascular and cerebrovacular complications form a major challenge in the management of the The Metabolic Syndrome. The risks of development are compounded by simultaneous occurrence of Type 2 diabetes mellitus (T2DM), dyslipid emias, hypertension and other medical conditions. The significant increase in morbidity, mortality along with premature death and disabilities resulting from these conditions in both developed and developing is a matter of great concern. The article makes a microanalysis of Biochemical alterations associated with dyslipidemias in cases of metabolic syndrome.

References

21 Cites in Article
  1. E Shafrir (1993). Animal models of syndrome X.
  2. P Lempiainen (1999). Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.
  3. (2001). Executive Summary of the Thyroid Report of National Cholesterol Education Program (NCEP).
  4. Pwf Wilson,D' Agostino,R Parise,H Sullivan,L Meigs,J (2005). The metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes.
  5. Delma Nieves,Miriam Cnop,Barbara Retzlaff,Carolyn Walden,John Brunzell,Robert Knopp,Steven Kahn (2003). The Atherogenic Lipoprotein Profile Associated With Obesity and Insulin Resistance Is Largely Attributable to Intra-Abdominal Fat.
  6. Robert Ross,Jennifer Freeman,Robert Hudson,Ian Janssen (2002). Abdominal Obesity, Muscle Composition, and Insulin Resistance in Premenopausal Women.
  7. Mark Danese,Paul Ladenson,Curtis Meinert,Neil Powe (2000). Effect of Thyroxine Therapy on Serum Lipoproteins in Patients with Mild Thyroid Failure: A Quantitative Review of the Literature*.
  8. B Wajchenberg (2000). Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome.
  9. D Nieves,M Cnop,B Retzlaff,C Walden,J Brunzell,R Knopp,S Kahn (2003). The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intraabdominal fat.
  10. I Lemieux,A Pascot,C Couillard,B Lamarche,A Tchernof,N Alme Ras,J Bergeron,D Gaudet,G Tremblay,D Prud'homme,A Nadeau,' Despre,Jp (2000). Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B, small, dense LDL) in men.
  11. Jean-Pierre Després,Alain Golay,Lars Sjöström (2005). Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia.
  12. Henry Ginsberg,Li-Shin Huang (2000). The Insulin Resistance Syndrome: Impact on Lipoprotein Metabolism and Atherothrombosis.
  13. Dennis Drayna,Alisha Jarnagin,John Mclean,William Henzel,William Kohr,Christopher Fielding,Richard Lawn (1987). Cloning and sequencing of human cholesteryl ester transfer protein cDNA.
  14. Richard Morton (1999). Cholesteryl ester transfer protein and its plasma regulator.
  15. T Arai,S Yamashita,K Hirano (1994). Increased plasma cholesteryl ester transfer protein in obese subjects: a possible mechanism for the reduction of serum HDL cholesterol levels in obesity.
  16. Raija Malmström,Christopher Packard,Timothy Watson,Sirpa Rannikko,Muriel Caslake,Dorothy Bedford,Philip Stewart,Hannele Yki-Järvinen,James Shepherd,Marja-Riitta Taskinen (1997). Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal Men.
  17. H Ginsberg,N-A Le,I Goldberg,J Gibson,A Rubinstein,P Wang-Iverson,R Norum,W Brown (1986). Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo..
  18. B Lamarchc,A Tchernof,P Mauriege (1998). Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart Disease.
  19. A Chatt,R Brazg,D Tribble (1993). Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.
  20. Peter Wilson,Scott Grundy (2003). The Metabolic Syndrome.
  21. P Barter,K Rye (1699). High density lipoproteins and coronary heart disease.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Dr. Ashfaq ul Hassan, Dr. Shazia Nazir. 2015. "Lipid Profile Alterations in the Metabolic Syndrome The Latest Biochemical and Physiological Aspect". Global Journal of Medical Research - F: Diseases GJMR-F Volume 15 (GJMR Volume 15 Issue F3).

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmr

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-F Classification NLMC Code: WD 200.5.H8
Version of record

v1.2

Issue date
August 3, 2015

Language
English
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 847
Total Downloads: 74
All Trends

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Lipid Profile Alterations in the Metabolic Syndrome The Latest Biochemical and Physiological Aspect

Dr. Hassan
Dr. Hassan SKIMS
Dr. Nazir
Dr. Nazir